Aptevo Therapeutics
APVO
APVO
9 hedge funds and large institutions have $18M invested in Aptevo Therapeutics in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
-4
Holders Change %
-30.77%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$2.32M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$1.53M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Citigroup
New York
| – | -$40K | – | – |
|
77
Group One Trading
Chicago,
Illinois
| – | -$1K | – | – |
|
|
PAM
78
Paradigm Asset Management
New York
| – | -$25.7K | – | – |
|
79
Renaissance Technologies
New York
| – | -$47K | – | – |
|
|
PCM
80
Prelude Capital Management
New York
| – | -$6K | – | – |
|
81
Allianz Asset Management
Munich,
Germany
| – | -$31K | – | – |
|
82
Creative Planning
Overland Park,
Kansas
| – | -$5K | – | – |
|
|
CIA
83
Capital Impact Advisors
Boston,
Massachusetts
| – | -$30K | – | – |
|
|
VIA
84
Vident Investment Advisory
Alpharetta,
Georgia
| – | -$35K | – | – |
|